Skip to content

Building vascular cognitive impairment cohort for study of Subcortical vascular dementia and Alzheimer's disease dementia

Building vascular cognitive impairment cohort for development of a dementia risk assessment system and identification of pathophysiologycal interaction between vascular aging and neurodegeneration.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005428
Enrollment
360
Registered
2020-09-24
Start date
2018-11-15
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Gachon University Gil Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Cognitively Normal (CN) • Normal cognition will be defined according to neuropsychological testing, which didn't fall within 1.5 SD, and Clinical Dementia Rating (CDR) was 0 . - Mild cognitive impairment (MCI): • CDR was 0.5 • Subjects were not be clinically diagnosed with dementia according to Diagnostic and Statistical Manual of Mental Disorders, 4th. Edition, Text-revision (DSM-IV-TR) criteria. - Dementia (AD and SVaD) - Alzheimer's disease (AD) • CDR = 0.5 • subjects were diagnosed with dementia according to DSM-IV-TR. • subjects were diagnosed with probable AD or possible AD according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) criteria. - Subcortical vascular dementia (SVaD) • CDR = 0.5 • Subjects were diagnosed with vascular dementia according to DSM-IV-TR. • In FLAIR images, whitematter hyperintensity was more than moderate according to the modified Fazeka’s scale.

Exclusion criteria

Exclusion criteria: - Subjects who do not meet the inclusion criteria. - Subjects who have history of any significant neurological disease other than AD or VD , such as traumatic brain injury, Parkinson's disease, Huntington's disease, motor neuron disease, or multiple sclerosis. - Subjects who have history of brain tumor, normal presure hydrocephalus, encephalitis, or metabolic encephalopathy. - Subjects who have history of a massive stroke in cerebrum, brain strem or cerebellum. - Subjects who have history of psychiatric disorder. - Subjects unable to undergo MRI or PET scanning. - Pregnent or reast feeding women.

Design outcomes

Primary

MeasureTime frame
Analysis of Cognitive Function and Brain Structural Changes Between Groups During Follow-up Assessments(Linear mixed model), and Evaluation of the Imp act on Cognitive Impairment and Brain Atrophy(Cox proportional hazard mode l)

Secondary

MeasureTime frame
Analysis of the Impact on Cognitive Function and Brain Structural Changes Bet ween Groups - Using Structural Equation Model and Relative Importance Meth od

Countries

Korea, Republic of

Contacts

Public ContactYoung Noh

Gachon University Gil Medical Center

ynoh@gachon.ac.kr+82-32-460-9043

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 2, 2026